Skip to main content

Patience David

In the past year, 2 open-market purchase filings worth $32.2K and no sales.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
$32.2K
2 filings
Sold
–
0 filings
Net
+$32.2K
Bought minus sold
Companies
1
With open-market trades

Trades

Every Form 4 that lists Patience David as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

TLSI TriSalus Life Sciences, Inc.

Chief Financial Officer2 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
May 18, 2026 (view filing)May 153 daysPatience DavidChief Financial OfficerPPurchase+7.10K$2.43+$17.3K+2.6%275.8K after
Feb 23, 2026 (view filing)Feb 23Same dayPatience DavidChief Financial OfficerPPurchase+3.66K$4.10+$15.0K+1.4%268.7K after

AXDX Accelerate Diagnostics, Inc

Chief Financial Officer13 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Apr 2, 2025 (view filing)Apr 11 dayPatience DavidChief Financial OfficerSSale−6.82K$0.71−$4.84K−9.5%64.6K after
Feb 27, 2025 (view filing)Feb 261 dayPatience DavidChief Financial OfficerSSale−535$1.09−$583.15−1.0%51.4K after
Apr 10, 2024 (view filing)Apr 91 dayPatience DavidChief Financial OfficerSSale−13.3K$0.87−$11.6K−20.9%50.4K after
Feb 27, 2024 (view filing)Feb 261 dayPatience DavidChief Financial OfficerSSale−350$0.96−$336−1.3%26.2K after
Dec 14, 2023 (view filing)Dec 131 dayPatience DavidChief Financial OfficerSSale−97$4.39−$425.83−1.1%8.93K after
Nov 14, 2023 (view filing)Nov 131 dayPatience DavidChief Financial OfficerSSale−97$5.57−$540.29−1.1%8.70K after
Oct 16, 2023 (view filing)Oct 133 daysPatience DavidChief Financial OfficerSSale−96$5.83−$559.68−1.1%8.46K after
Sep 14, 2023 (view filing)Sep 131 dayPatience DavidChief Financial OfficerSSale−96$6.53−$626.88−1.2%8.23K after
Aug 15, 2023 (view filing)Aug 141 dayPatience DavidChief Financial OfficerSSale−95$6.80−$646−1.2%7.99K after
Jul 17, 2023 (view filing)Jul 134 daysPatience DavidChief Financial OfficerSSale−92$6.90−$634.8−1.2%7.76K after

See all 13 trades at AXDX